Mohl, D.A.; Lagies, S.; Zodel, K.; Zumkeller, M.; Peighambari, A.; Ganner, A.; Plattner, D.A.; Neumann-Haefelin, E.; Adlesic, M.; Frew, I.J.;
et al. Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma. Cells 2023, 12, 1102.
https://doi.org/10.3390/cells12081102
AMA Style
Mohl DA, Lagies S, Zodel K, Zumkeller M, Peighambari A, Ganner A, Plattner DA, Neumann-Haefelin E, Adlesic M, Frew IJ,
et al. Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma. Cells. 2023; 12(8):1102.
https://doi.org/10.3390/cells12081102
Chicago/Turabian Style
Mohl, Daniel A., Simon Lagies, Kyra Zodel, Matthias Zumkeller, Asin Peighambari, Athina Ganner, Dietmar A. Plattner, Elke Neumann-Haefelin, Mojca Adlesic, Ian J. Frew,
and et al. 2023. "Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma" Cells 12, no. 8: 1102.
https://doi.org/10.3390/cells12081102
APA Style
Mohl, D. A., Lagies, S., Zodel, K., Zumkeller, M., Peighambari, A., Ganner, A., Plattner, D. A., Neumann-Haefelin, E., Adlesic, M., Frew, I. J., & Kammerer, B.
(2023). Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma. Cells, 12(8), 1102.
https://doi.org/10.3390/cells12081102
